These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22997913)

  • 21. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
    Smilde TD; Asselbergs FW; Hillege HL; Voors AA; Kors JA; Gansevoort RT; van Gilst WH; de Jong PE; Van Veldhuisen DJ
    Am J Hypertens; 2005 Mar; 18(3):342-7. PubMed ID: 15797651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China.
    Dai D; Chang Y; Chen Y; Yu S; Guo X; Sun Y
    BMC Cardiovasc Disord; 2017 Jan; 17(1):24. PubMed ID: 28086799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
    Kimura T; Iio K; Obi Y; Hayashi T
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
    Chang JM; Chen SC; Huang JC; Su HM; Chen HC
    Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
    Bregman R; Lemos C; Pecoits Filho R; Abensur H; Draibe S; Bastos MG; Canziani ME
    J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors of myocardial remodeling in hemodialysis patients.
    Dimitrijevic Z; Cvetkovic T; Stojanovic M; Paunovic K; Djordjevic V
    Ren Fail; 2009; 31(8):662-7. PubMed ID: 19817519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease.
    Zou J; Yu Y; Wu P; Lin FJ; Yao Y; Xie Y; Jiang GR
    Int J Cardiol; 2016 Oct; 221():134-40. PubMed ID: 27400310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience.
    Ali T; Idrees MK; ; Akhtar SF
    Saudi J Kidney Dis Transpl; 2017; 28(6):1375-1380. PubMed ID: 29265050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).
    Leonardis D; Basta G; Mallamaci F; Cutrupi S; Pizzini P; Tripepi R; Tripepi G; De Caterina R; Zoccali C
    Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):748-55. PubMed ID: 21470837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E; Cannella G
    G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II; Arodiwe EB; Ijoma CK
    Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of day-to-day arterial pressure variability on the left ventricle geometry in patients with predialysis chronic kidney insufficiency].
    Shutov AM; Kondrat'eva NI; Kulikova ES; Ivashkina TN
    Ter Arkh; 2002; 74(6):42-5. PubMed ID: 12136482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors associated with change rates of LV hypertrophy and renal dysfunction in CKD patients.
    Okumura K; Io H; Matsumoto M; Seto T; Takagi M; Masuda A; Furukawa M; Nagahama L; Omote K; Hisada A; Hamada C; Horikoshi S; Tomino Y
    Clin Nephrol; 2013 Jan; 79(1):7-14. PubMed ID: 23036229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.